PSY72 – Orphan Drug Pricing In France: Influence of Main Factors
Grand, H.; Samson, Anne-Laure; Aulois-Griot, M. (2014), PSY72 – Orphan Drug Pricing In France: Influence of Main Factors, Value in Health, 17, 7, p. A534. 10.1016/j.jval.2014.08.1702
Type
Article accepté pour publication ou publiéDate
2014-11Journal name
Value in HealthVolume
17Number
7Publisher
Elsevier
Pages
A534
Publication identifier
Metadata
Show full item recordAbstract (EN)
Orphan drugs (OD) require considerable expenditures, which causes difficulties in their market access. For several years, the price of these new therapies has often been criticized and considered as too high. However few studies about OD pricing mechanisms are available. The aim of the paper is to highlight the main factors that influence OD pricing in France.Subjects / Keywords
Drugs; Health expendituresRelated items
Showing items related by title and author.
-
Fair Cost-Benefit Evaluation of Health Care: a Case Study of Blood Pressure Lowering Drugs in France Dormont, Brigitte; Luchini, Stéphane; Samson, Anne-Laure; Schokkaert, Erik; Thébaut, Clémence; Van de Voorde, Carine (2012) Communication / Conférence
-
Samson, Anne-Laure; Thébaut, Clémence; Dormont, Brigitte; Fleurbaey, Marc; Luchini, Stéphane; Schokkaert, Erik; Van de Voorde, Carine (2014) Communication / Conférence
-
The Introduction of Pay-for-Performance: What Impact on General Practitioners' Activity in France? Dormont, Brigitte; Kingsada, Aimée; Samson, Anne-Laure (2021) Article accepté pour publication ou publié
-
Duran-Vigneron, Pascale; Breuillé, Marie-Laure; Samson, Anne-Laure (2013-06) Communication / Conférence
-
Dormont, Brigitte; Samson, Anne-Laure (2014) Document de travail / Working paper